Clinical Trials Sponsored by MED Institute Inc.
Total 6673 results
-
MED Institute Inc.CompletedOrthopedic Disorder | WoundUnited States
-
MED Institute Inc.Active, not recruitingVenous Insufficiency of LegColombia
-
MED Institute Inc.Signature BiologicsAvailable
-
BeBetter Med IncRecruitingAdvanced Triple-Negative Breast CancerChina
-
BeBetter Med IncCompleted
-
BeBetter Med IncNot yet recruitingNon Small Cell Lung CancerChina
-
BeBetter Med IncCompletedRelapsed or Refractory Multiple Myeloma | Relapsed or Refractory Non-Hodgkin's LymphomaChina
-
BeBetter Med IncActive, not recruitingRelapsed or Refractory Diffuse Large B-cell LymphomaChina
-
BeBetter Med IncRecruitingRelapsed/Refractory Diffuse Large B-Cell LymphomaChina
-
BeBetter Med IncRecruitingNon-Small Cell Lung Cancer | EGFR Exon 20 Insertion MutationChina
-
BeBetter Med IncRecruitingRelapsed/Refractory Diffuse Large B-Cell LymphomaChina
-
EMD Serono Research & Development Institute, Inc.CompletedMultiple SclerosisLebanon, United States, Turkey, Sweden, Finland, France, Thailand, Serbia, Italy, United Kingdom, United Arab Emirates, Bulgaria, Belgium, Estonia, Argentina, Austria, Bosnia and Herzegovina, Canada, Croatia, Czechia, Georgia, Ger... and more
-
EMD Serono Research & Development Institute, Inc.Completed
-
EMD Serono Research & Development Institute, Inc.Terminated
-
EMD Serono Research & Development Institute, Inc.CompletedCarcinoma, Merkel CellUnited States, Spain, Australia, Italy, Germany, France, Japan
-
EMD Serono Research & Development Institute, Inc.CompletedRelapsing-Remitting Multiple SclerosisCroatia, United States, Bulgaria, France, Italy, Russian Federation, Turkey, United Kingdom, Estonia, Germany, Latvia, Lithuania, Poland, Austria, Brazil, Canada, Finland, Portugal, Greece, Serbia, Denmark, Ukraine, Saudi Arabia, Lebanon and more
-
EMD Serono Research & Development Institute, Inc.CompletedMultiple SclerosisUnited States, Italy, Russian Federation, Spain
-
Radiomedix, Inc.Orano Med LLCActive, not recruitingNeuroendocrine TumorsUnited States
-
Criterium, Inc.EMD Serono Research & Development Institute, Inc.TerminatedAdvanced Non-Small Cell Lung Cancer With MET MutationsUnited States
-
Radiomedix, Inc.Orano Med LLCRecruiting
-
XeltisQ-Med Scandinavia, Inc.CompletedHeart Defects, CongenitalRussian Federation
-
AbSolutions Med Inc.Cogent Technologies CorporationRecruiting
-
AbSolutions Med Inc.Cogent Technologies CorporationNot yet recruiting
-
Composite Interceptive Med ScienceBioxytran Inc.Completed
-
Mayo ClinicChek-Med Systems, Inc.Terminated
-
QED Therapeutics, Inc.Enrolling by invitationAchondroplasiaUnited States, Spain, United Kingdom, France, Australia, Canada
-
MEI Pharma, Inc.TerminatedMarginal Zone Lymphoma | Non Hodgkin Lymphoma | Follicular Lymphoma (FL)United States, Spain, Korea, Republic of, Belgium, Taiwan, Germany, France, Italy, Australia, Poland, New Zealand, United Kingdom, Austria, Switzerland
-
QED Therapeutics, Inc.Enrolling by invitationAchondroplasiaAustralia, United States, Argentina, Canada, France, Italy, Norway, Singapore, Spain, United Kingdom
-
QED Therapeutics, Inc.RecruitingAchondroplasiaUnited States, Spain, Singapore, Canada, United Kingdom, France, Australia, Norway, Argentina, Germany, Italy
-
QED Therapeutics, Inc.Enrolling by invitationHypochondroplasiaUnited States, Singapore, Norway, Australia, France, Canada, Portugal, United Kingdom, Spain, Sweden
-
MEI Pharma, Inc.TerminatedChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Mantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Marginal Zone B Cell Lymphoma | High Grade Non-Hodgkin's LymphomaUnited States, Switzerland
-
MEI Pharma, Inc.CompletedProstate CancerUnited States
-
QED Therapeutics, Inc.RecruitingHypochondroplasiaUnited States, Norway, Singapore, United Kingdom, Australia, Portugal, France, Germany, Sweden, Canada, Spain
-
MEI Pharma, Inc.RecruitingChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Acute Myeloid Leukemia (AML) | Mantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Marginal Zone Lymphoma (MZL)United States
-
MEI Pharma, Inc.TerminatedColorectal CancerUnited States
-
QED Therapeutics, Inc.Active, not recruitingAchondroplasiaUnited States, United Kingdom, Spain, France, Australia, Canada
-
MEI Pharma, Inc.CompletedPeritoneal Neoplasms | Ovarian Cancer | Fallopian Tube CancerUnited States, Spain, Belgium, United Kingdom, Australia, Italy, Poland
-
MEI Pharma, Inc.CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States, Australia
-
MED-LIFE DISCOVERIES LPBioPharma Services, IncRecruitingRhizomelic Chondrodysplasia PunctataCanada
-
South Shore HospitalQ-Med Scandinavia, Inc.Terminated
-
Raghu Nandan, M.D., IncUnknownCombination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerLung CancerUnited States
-
Raghu Nandan, M.D., IncUnknown
-
Jacob Soumerai, MDMEI Pharma, Inc.WithdrawnRelapsed Follicular Lymphoma | Refractory Follicular LymphomaUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingCancer | Lung CancerKorea, Republic of, Spain, Germany, Japan, Taiwan, China, Italy, United States, Belgium, Russian Federation, Turkey, Ukraine
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingMetastatic or Locally Advanced Unresectable Solid TumorsUnited States, China, Spain, Japan, United Kingdom
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingNon-small Cell Lung CancerKorea, Republic of, Taiwan, United States, China, Hong Kong, France, Russian Federation, Netherlands, Japan, Spain, Italy, Belgium, Vietnam, Malaysia, Thailand, Germany, Singapore
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingCentral Nervous System TumorsKorea, Republic of, Canada, Germany, France
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedMetastatic or Locally Advanced Unresectable Solid TumorsUnited States, Canada
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedAdvanced Solid TumorsUnited States, Germany, Norway, Netherlands, Belgium, Denmark, Sweden, Switzerland
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyWithdrawnUrothelial CarcinomaUnited States, Germany